Clinical Trial Update: Mifepristone in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating mifepristone for recurrent or persistent ovarian epithelial, primary peritoneal, or fallopian tube cancer has completed, with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Mifepristone (mifepristone)

Snippet

Sponsor: Gynecologic Oncology Group | Conditions: Fallopian Tube Cancer, Ovarian Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-06-18